ライフサイエンスコーパス: viral transmission

1 synapses, thereby facilitating cell-to-cell viral transmission.

2 the establishment of KSHV/HHV8 infection and viral transmission.

3 ctivities, and responds by initiating active viral transmission.

4 CTL activity and protection against mucosal viral transmission.

5 response timed with virus exposure can limit viral transmission.

6 esulting immune stimulation is essential for viral transmission.

7 d in colon and may therefore be important in viral transmission.

8 n of apoptosis is essential for this mode of viral transmission.

9 affect host resistance or susceptibility to viral transmission.

10 e and effective method to reduce the risk of viral transmission.

11 e opportunity to explore parameters defining viral transmission.

12 portant for future monitoring and tracing of viral transmission.

13 e virions in seawater, potentially enhancing viral transmission.

14 explain differences in clinical disease and viral transmission.

15 ice precludes the study of foetal (vertical) viral transmission.

16 pism that are preferentially associated with viral transmission.

17 of disease progression and the likelihood of viral transmission.

18 tory tract, which could significantly reduce viral transmission.

19 therin actually enhances direct cell-to-cell viral transmission.

20 for subsequent patients, likely resulted in viral transmission.

21 ence, and they suggest a fecal-oral route of viral transmission.

22 e sought to identify the gB-mediated step in viral transmission.

23 at mucosal portals of virus entry to prevent viral transmission.

24 e lack of HIV-1 retention-mediated long-term viral transmission.

25 the HIV epidemic and assumptions made about viral transmission.

26 whether this approach could reduce rates of viral transmission.

27 increased cost, and the theoretical risk of viral transmission.

28 4 by Nef expression correlated with enhanced viral transmission.

29 associated thrombotic events or evidence of viral transmission.

30 However, the mechanism of viral transmission across the mucosal barrier is poorly

31 ide examples of how it may negatively impact viral transmission among hosts.

32 on is generally characterized by inefficient viral transmission; an acute phase of intense viral repl

33 ope, both key requirements for prevention of viral transmission and clearance of pathogenic HIV from

34 Mathematical models of viral transmission and control are important tools for a

35 against R5 HIV-1 can be expected to prevent viral transmission and delay disease progression.

36 f PERV inactivation to prevent cross-species viral transmission and demonstrates the successful produ

37 set-point viral load strongly predicts both viral transmission and disease progression.

38 fection and to decrease the related risks of viral transmission and emergence of drug resistance.

39 f microwave irradiation for the reduction of viral transmission and establishment of this safety stra

40 ever, the effects of this immune pressure on viral transmission and evolution have not been determine

41 ained by host factors predicted to influence viral transmission and find that internal fertilization

42 ddition to providing fundamental concepts in viral transmission and immune responses against HTLV-1 i

43 zing the functions of subtype-E env genes in viral transmission and pathogenesis and for vaccine chal

44 cells promises to provide new insights into viral transmission and pathogenesis, and opens new avenu

45 these polymorphisms can be analyzed to study viral transmission and pathogenesis.

46 perantigens in B lymphocytes is required for viral transmission and pathogenesis.

47 because VZV skin infection is necessary for viral transmission and persistence in the human populati

48 Modern farming conditions may also increase viral transmission and potential zoonotic spread.

49 y HIV-1 and may have a potential role during viral transmission and spread in vivo.

50 t-specific susceptibility factors that alter viral transmission and subsequent disease progression.

51 nt HIV-1-neutralizing antibodies can prevent viral transmission and suppress an ongoing infection.

52 bset in HIV infection because they influence viral transmission and target cell infection and present

53 modulation of this pathway is important for viral transmission and the lifelong persistence of herpe

54 V strains may provide important insight into viral transmission and the mechanisms of SIV- and HIV-in

55 in all infants, regardless of the timing of viral transmission and the rate of disease progression.

56 double-targeted antivirals that can prevent viral transmission and treat the 2 synergistic diseases

57 Viral transmission, and graft and patient outcomes were

58 e effects of anti-HBc Ab (+) donor status on viral transmission, and graft and patient survival.

59 n persistence and the effect of pregnancy on viral transmission, as well as an accurate quantitation

60 synapses, which contributes to mDC-enhanced viral transmission, at least in part.

61 rus pathogenicity, and (iii) the pathways of viral transmission between different holdings and sheds.

62 emagglutinin protein confer the capacity for viral transmission between ferrets.

63 We found evidence for viral transmission between the two host populations thou

64 However, because the risk for viral transmission by allogeneic transfusion is already

65 nfectious, suggesting potential capacity for viral transmission by the oral route.

66 The risk for viral transmission by transfusion has been reduced drama

67 es have estimated bottleneck sizes governing viral transmission by using statistical analyses of vari

68 at long-lasting immune resistance to mucosal viral transmission can be accomplished by CD8(+) CTL tha

69 major histocompatibility complex [MHC]) and viral transmission (CD4 and DC-SIGN).

70 s observed, and finally, interruption of the viral transmission chain occurred after the14th pig pass

71 ternative theory that for a new vector borne viral transmission cycle to start, an outbreak of an ove

72 because it serves as a powerful cofactor for viral transmission, disease progression, and AIDS-relate

73 e Zika virus genome (ZIKV-3'UTR-LAV) prevent viral transmission during pregnancy and testis damage in

74 viruses, but uncertainties remain regarding viral transmission dynamics and mechanisms of persistenc

75 elds that contribute to our understanding of viral transmission dynamics in heterogeneous host popula

76 an primate challenge system for the study of viral transmission, evaluation of vaccines and other pre

77 ulations, and thereby substantially limiting viral transmission even in resource-poor settings.

78 ection with the potential for reinfection or viral transmission even in the presence of strong and di

79 afety concerns in developed countries, where viral transmission from contaminated blood or blood prod

80 t evaluate the cost-effectiveness or risk of viral transmission from fibrin glue.

81 Evidence for transient viral transmission from infected to uninfected cells is

82 iants in Eurasia could be the consequence of viral transmission from Neanderthals/Denisovans to non-A

83 A respiratory route of viral transmission has also been hypothesized implicatin

84 mucosa to mediate protection against mucosal viral transmission has never been proven.

85 the authors conducted a prospective study of viral transmission in a cohort of 684 children in Lusaka

86 nited States as a model to gain insight into viral transmission in a setting of high interspecies con

87 can convert to an HA that supports efficient viral transmission in mammals; however, we do not know w

88 ated HBcAb+ donors represent minimal risk of viral transmission in vaccinated lung transplant (LTx) r

89 ture and rainfall play in controlling dengue viral transmission including discussions of the effect o

90 ction factors, cellular structures promoting viral transmission including the infectious synapse or t

91 his site has been difficult to determine, as viral transmission is sporadic, pathogenesis is complica

92 These results suggest that VHSV persists and viral transmission may be active in Lake Winnebago even

93 imity of some WS and LBM loNDV suggests that viral transmission may occur among wild birds and poultr

94 sults led us to speculate that prevention of viral transmission may require IgA antibodies or cellula

95 modeling in order to determine and quantify viral transmission modes.

96 l issues of the greatest importance, such as viral transmissions; nosocomial, or healthcare-associate

97 e estimate that 39% (95% CI: 34%-42%) of new viral transmissions occur within stable household partne

98 regulating the pathogenesis, virulence, and viral transmission of AIV in chickens.

99 Both cell-associated and cell-free viral transmission of HHV-6A into the peritoneal cavity

100 remarkably effective in preventing maternal-viral transmission of HIV during pregnancy.

101 ignificance (that is, the ability to enhance viral transmission) of viral gene products that interfer

102 ion, allowing us to characterize patterns of viral transmission over the initial weeks of the epidemi

103 s, but little is known about NK cells during viral transmission, particularly in mucosal tissues.

104 an alternate, CD46-independent mechanism of viral transmission, possibly through the synapse.

105 ine is likely to have the greatest impact on viral transmission rates.

106 nt need for assessment of factors that allow viral transmission, replication, and intra-airway spread

107 ncy virus (HIV) type 1 infection in terms of viral transmission, replication, and pathogenesis.

108 SIV (i.e., whether the genetic bottleneck of viral transmission reported in humans and macaques is al

109 ne receptors, CCR5 is the most important for viral transmission, since CCR5 is the principal receptor

110 Modelling analysis suggests that viral transmission started in early January, which is co

111 virus (EBV) is an orally transmitted virus, viral transmission through the oropharyngeal mucosal epi

112 le to HIV-1 infection and mediated efficient viral transmission to CD4(+) T cells.

113 though adhesion of MV-infected monocytes and viral transmission to ECs was demonstrated, strain-speci

114 infectious EBV and is a potential source of viral transmission to infants living in malaria-endemic

115 remains controversial because of concern for viral transmission to recipients.

116 e by fully LPS-matured DC resulted in higher viral transmission to target cells but poorer stimulatio

117 ed in allogeneic T lymphocyte activation, in viral transmission to transiently adherent leukocytes an

118 Viral transmission via the ocular route was assessed in

119 Cell-to-cell viral transmission via virological synapses has been arg

120 reat, methods that have been shown to reduce viral transmission warrant renewed attention.

121 we observed that the extent of resistance to viral transmission was higher in animals immunized with

122 ll surface and to increase cell adhesion and viral transmission was not affected by the C39A mutation

123 DC-mediated viral transmission was significantly inhibited when both

124 standing of the Env regulation that precedes viral transmission, we examined the nanoscale organizati

125 As an alternative to a stochastic model of viral transmission, we hypothesize that viral selection

126 -21 plasmid produced sustained resistance to viral transmission when injected 5 days after DNA vaccin

127 This study reveals a novel mode of viral transmission, where enteroviral genomes are transm

128 Risk of viral transmission with HCV Ab+ allografts seems high af

129 Notably, viral transmission within these cultures occurred in the

130 of mammalian viromes can help trace paths of viral transmissions within or between species.